The acquisition brings Gallant’s experimental stem cell treatments for chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
A recently published stud found that house soiling in aging dogs tracked with poorer performance on executive function tasks and with lower urine specific gravity, but not with pyuria, bacteriuria, or proteinuria.